Guaifenesin

Renibus Announces Leadership Transition

Retrieved on: 
Thursday, March 21, 2024

SOUTHLAKE, Texas, March 21, 2024 /PRNewswire/ -- Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio-renal and metabolic diseases, today announced a transition in its leadership structure. As part of this change, Frank Stonebanks, former co-CEO, has left the company to pursue new opportunities.  Renibus wishes Mr. Stonebanks the best in his future endeavors. Jeffrey Keyser, RPh, JD, PhD, co-founder and former co-CEO, has been appointed President and CEO of Renibus.

Key Points: 
  • SOUTHLAKE, Texas, March 21, 2024 /PRNewswire/ -- Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio-renal and metabolic diseases, today announced a transition in its leadership structure.
  • Jeffrey Keyser, RPh, JD, PhD, co-founder and former co-CEO, has been appointed President and CEO of Renibus.
  • Prior to co-founding Renibus, Dr. Keyser invented the Mucinex product line for Adams Respiratory Therapeutics, Inc. and co-founded ZS Pharma, Inc. (acquired by Astra Zeneca Plc).
  • His leadership has been instrumental in Renibus' success to date and he is well positioned to lead the company into its next phase of growth and innovation.

MUCUS DISAPPEARUS! Mucinex Partners with Legendary Magicians Penn & Teller to Make Mr. Mucus - the Epitome of Colds and Coughs - DISAPPEAR!

Retrieved on: 
Thursday, February 1, 2024

PARSIPPANY, N.J., Feb. 1, 2024 /PRNewswire/ -- When you're sick with a cold, don't you just wish all those pesky symptoms would magically disappear? (The cough! The chest congestion!). That's why Mucinex, a Reckitt brand and the #1 most trusted brand by physicians for cough & cold symptoms*, is teaming up with legendary magicians Penn & Teller to pull off a jaw-dropping feat for the ages: The two Las Vegas mainstays are making Mucinex's nefarious mascot Mr. Mucus vanish into thin air… and they're doing it live! 

Key Points: 
  • "For years, Mr. Mucus has caused misery with cough and chest congestion, especially during peak cold and flu season," said Penn.
  • "We're beyond thrilled to be partnering with Penn & Teller," said Albert So, Marketing Director, Upper Respiratory Brands at Reckitt.
  • "Who better than this legendary magician-comedian duo to demonstrate the effectiveness of Mucinex 12-Hour, the #1 doctor recommended expectorant*?
  • Find out yourself by joining Penn & Teller in Grand Central Terminal's Vanderbilt Hall on Wednesday, February 7th from 12pm – 1pm.

National Survey from Mucinex® 12-Hour Reveals Americans Feel Healthy Only Six Months Out of the Year

Retrieved on: 
Friday, January 12, 2024

PARSIPPANY, N.J., Jan. 12, 2024 /PRNewswire/ -- Over the last year, how many days did you feel sick and not at your best? In a recent survey of 2,000 adults, Americans responded that they're on their "A" game only about 15 days per month. What's more, 46% of Americans admit that they actively worry about missing out on important events and experiences with their loved ones. That's why Mucinex 12-Hour, the #1 doctor recommended expectorant, today announced the launch of its new "Power of 12" campaign, an initiative that kicks off on 1/12 to spotlight its efficacy: one little pill that delivers 12 full hours of symptom relief, so they can spend less time suffering, and more time doing the things you love.

Key Points: 
  • In a recent survey of 2,000 adults, Americans responded that they're on their "A" game only about 15 days per month.
  • What's more, 46% of Americans admit that they actively worry about missing out on important events and experiences with their loved ones.
  • Americans certainly wish they had more hours in the day, according to key results from the survey, commissioned by Mucinex and conducted by market research company OnePoll.
  • The top three reasons Americans tend to feel unwell: lack of sleep (43%), excessive stress (43%) and being sick (22%).

Hi-Tech Pharmaceuticals Expands Production Capabilities in Dietary Supplement and OTC Drug Manufacturing

Retrieved on: 
Wednesday, January 3, 2024

The OTC product (guaifenesin 1200-mg and dextromethorphan HBr 60-mg extended-release tablets) is indicated to control coughs and break up mucus in order to make coughs more productive.

Key Points: 
  • The OTC product (guaifenesin 1200-mg and dextromethorphan HBr 60-mg extended-release tablets) is indicated to control coughs and break up mucus in order to make coughs more productive.
  • Upper respiratory treatments are the single biggest over-the-counter drug category, according to the nonprofit Consumer Healthcare Protection Association.
  • Since 1979, Hi-Tech Pharmaceuticals has been providing quality custom manufacturing services to the pharmaceutical, dietary supplement and beverage industries.
  • Hi-Tech Pharmaceuticals is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products with customers throughout the world.

ROMPE PECHITO ®, New Product With Natural Extracts for Children’s Cough Relief

Retrieved on: 
Wednesday, October 25, 2023

Recently Efficient Laboratories, a Puerto Rican company dedicated to the distribution of its own health care brands, launched a new product, ROMPE PECHITO ®, an over-the-counter medicine for children to relieve cold symptoms.

Key Points: 
  • Recently Efficient Laboratories, a Puerto Rican company dedicated to the distribution of its own health care brands, launched a new product, ROMPE PECHITO ®, an over-the-counter medicine for children to relieve cold symptoms.
  • View the full release here: https://www.businesswire.com/news/home/20231025483780/en/
    Rompe Pechitos® DM is the newest addition to our Rompe Pecho® family.
  • This product is based on a natural ingredient formula with honey and elderberry extract that has proven effective in treating symptoms associated with colds.
  • It is recommended to consult a doctor or pharmacist if you have any questions, and use the product as directed.

MUCINEX NAMED OFFICIAL COLD & FLU MEDICINE PARTNER OF THE NEW YORK RANGERS

Retrieved on: 
Monday, October 16, 2023

NEW YORK, Oct. 16, 2023 /PRNewswire/ -- Madison Square Garden Sports Corp. (NYSE: MSGS) announced today a marketing partnership with Mucinex, naming America's #1 doctor trusted cough & cold brand, the Official Cold & Flu Partner of the New York Rangers. Through the partnership, Mucinex will receive significant brand promotion during Rangers games at The Garden, including dasherboard signage, virtual dasherboard signage during games broadcasted on MSG Network and promotional in-game features on GardenVision. 

Key Points: 
  • Rangers and Mucinex to Partner on an Artemi Panarin Bobblehead Giveaway for Rangers vs. Seattle Kraken Game on Tues., January 16
    Mucinex Will be Integrated Across Rangers Digital Platforms and During Rangers Games at The Garden, Including Brand Exposure and Unique Activations
    NEW YORK, Oct. 16, 2023 /PRNewswire/ -- Madison Square Garden Sports Corp. (NYSE: MSGS) announced today a marketing partnership with Mucinex, naming America's #1 doctor trusted cough & cold brand, the Official Cold & Flu Partner of the New York Rangers.
  • "Mucinex is a world-renowned brand who has always valued their customers, much like the New York Rangers.
  • Additionally, Mucinex will partner with the Rangers digital team on an original content series that will be shown across Rangers digital channels.
  • Mucinex will also receive promotion on MSG Networks during the airing of Rangers regular season game telecasts.

Genexa Launches New Clean Cough & Cold Medicines for Kids

Retrieved on: 
Tuesday, September 19, 2023

Ahead of the 2024 cold and flu season, Genexa has today introduced new clean over-the-counter (OTC) kids’ medicine innovations, further reinforcing the company’s pioneering role in bringing clean, effective medicines to consumers.

Key Points: 
  • Ahead of the 2024 cold and flu season, Genexa has today introduced new clean over-the-counter (OTC) kids’ medicine innovations, further reinforcing the company’s pioneering role in bringing clean, effective medicines to consumers.
  • The new Kids’ Multi-Symptom Cold & Flu and Kids’ Daytime + Nighttime Cough Relief Value Pack provide parents with much-needed clean OTC options with the same effective active ingredients as legacy brands but without any dyes and artificial sweeteners, parabens, or common allergens.
  • “With Genexa’s product innovations, launching today in the kids’ cough & cold category, parents who are committed to clean products will have effective and clean medicine options to turn to this winter.”
    Like all of Genexa’s products, the latest kids’ innovations are available at Walmart, Walgreens, and on Amazon.
  • As a Certified B-Corporation, Genexa is committed to using business as a force for good, meeting rigorous standards of social and environmental performance, accountability, and transparency.

Mucinex® Fast-Max Cold & Flu All In One Teams Up with Two-Time Olympic Gold Medalist, Chloe Kim to Launch "Small But Mighty" Campaign

Retrieved on: 
Wednesday, February 22, 2023

PARSIPPANY, N.J., Feb. 22, 2023 /PRNewswire/ -- As we all continue to navigate another hard-hitting cold and flu season, Mucinex – a Reckitt brand and America's #1 doctor trusted cough & cold brand – is on a mission to help communities everywhere feel better, stay well and comeback from their cold and flu symptoms. Mirroring the powerful multi-symptom relief that Mucinex Fast-Max offers with one small dose, the brand is launching its Small But Mighty Campaign to show consumers that they can treat their cold & flu with less liquid per dose. *

Key Points: 
  • "The Small But Mighty Campaign illustrates how powerful relief can start with one small dose, and that consumers can take control over their cold & flu symptoms with Mucinex Fast-Max All In One."
  • Teaming up with Mucinex is one of the most celebrated winter athletes in recent years, two-time Olympic gold medalist, Chloe Kim, the first female in history to win back-to-back Olympic gold medals in halfpipe snowboarding.
  • "I am thrilled to partner with Mucinex to help bring awareness of the impact something 'small but mighty' can have during this cold & flu season," said Chloe Kim.
  • "50% more concentrated per ml vs the leading daytime severe cold & flu remedy* (Source: Nielsen latest 52 weeks ending 10/2022)."

Jessica Biel's KinderFarms Launches Clean Medicine Brand KinderMed

Retrieved on: 
Tuesday, November 15, 2022

NEW YORK, Nov. 15, 2022 /PRNewswire/ -- KinderFarms, the Kinder Farmaceutical Company, is proud to announce the launch of KinderMed – a line of clean children's medicines, made with clinically proven active ingredients, but clean, Kinder inactive ingredients.

Key Points: 
  • NEW YORK, Nov. 15, 2022 /PRNewswire/ --KinderFarms, the Kinder Farmaceutical Company, is proud to announce the launch of KinderMed a line of clean children's medicines, made with clinically proven active ingredients, but clean, Kinder inactive ingredients.
  • KinderFarms was co-founded by parents Jessica Biel and Jeremy Adams when they couldn't find children's health products that were both effective and aligned with their values.
  • So they set out to fill the gap in the pharmacy aisle for clean, effective options for families who share their values.
  • "We created KinderMed because we believe that no parent should ever have to choose between non-toxic and effective when it comes to their child's healthcare products."

Reckitt Launches Nationwide Case-Finding Initiative to Help Primary Care Providers Identify Millions of Undiagnosed COPD Patients

Retrieved on: 
Monday, November 7, 2022

PARSIPPANY, N.J., Nov. 7, 2022 /PRNewswire/ -- Chronic obstructive pulmonary disease, commonly referred to as COPD, affects 16 million adults nationwide, with another 16 million or more remaining undiagnosed*. A progressive disease with a poor prognosis, COPD diminishes quality of life, causes chronic respiratory symptoms and increases mortality. November is National COPD Awareness Month, and Reckitt – the leading hygiene, health and nutrition company behind household brands Mucinex, Delsym, and Lysol – is launching a nationwide education program to help raise awareness of the importance of early diagnoses of COPD and the vital role primary care physicians can play.

Key Points: 
  • A progressive disease with a poor prognosis, COPD diminishes quality of life, causes chronic respiratory symptoms and increases mortality.
  • November is National COPD Awareness Month, and Reckitt the leading hygiene, health and nutrition company behind household brands Mucinex, Delsym, and Lysol is launching a nationwide education program to help raise awareness of the importance of early diagnoses of COPD and the vital role primary care physicians can play.
  • "Our purpose at Reckitt is to protect, heal and nurture; and everything we do and make helps advance that purpose," said Tina Terraciano, Associate Director, Medical Marketing at Reckitt.
  • Guaifenesin has a professional indication for thinning and loosening mucus in patients with stable chronic bronchitis, one of the common conditions that contribute to COPD.